Accelerating Cervical Cancer Elimination in Africa
The Africa Centers for Disease Control (Africa CDC) recently announced a significant initiative to establish three Centers of Excellence in Rwanda, Morocco, and Zambia. This strategic move aims to gather evidence and accelerate efforts to eliminate cervical cancer in Africa by 2030. With a focus on technical collaboration, the meeting in Addis Ababa gathered various stakeholders to endorse a roadmap for improved vaccination, diagnostics, and treatment.
Recognizing Success Across Continents
Rwanda’s Innovative Approach
Rwanda was chosen for its remarkable achievement of a 90% HPV vaccination coverage rate since 2011. It stands out for its decentralized treatment approach across 22 districts and 350 health centers, setting a benchmark for other nations.
Morocco’s Healthcare Leadership
Morocco’s leadership in healthcare is evident through its successful implementation of school-based vaccination and establishment of regional cancer centers. This ensures accessible treatment and serves as a model for integrating primary healthcare.
Zambia’s Comprehensive Screening Efforts
Zambia made a substantial impact by screening over 1.9 million women and introducing advanced treatment technologies. This extensive initiative makes Zambia an ideal location for a Center of Excellence.
Commitment to Regional Strategy
The consultative meeting reinforced Member States’ resolve to expedite the cervical cancer regional strategy. The roadmap contains actionable recommendations aimed at improving HPV vaccination, diagnostics, and treatment over the coming years.
Technical Guidance and Peer Learning
Dr. Adelard Kakunze from Africa CDC emphasized the creation of a Technical Working Group and Centers of Excellence. These entities will ensure sustainability and foster peer learning across the continent, pivotal to the strategy’s success.
Aligning with Global Targets
The WHO’s ‘Global Strategy for the Elimination of Cervical Cancer as a Public Health Problem’ outlines 90-70-90 targets for 2030. This involves vaccinating 90% of girls, screening 70% of women, and ensuring treatment for 90% of those diagnosed with cervical disease.
Innovative Vaccination Strategies
Africa CDC’s endorsement of a single-dose HPV vaccine schedule, based on WHO’s Strategic Advisory Group of Experts on Immunisation recommendations, aims to boost vaccination rates efficiently. This strategy reflects the cost savings and increased accessibility crucial for meeting the 90% target.
The Role of Leadership in Securing Resources
Dr. Zainab Shinkafi Bagudu, Chairperson of First Ladies Against Cancer (FLAC), emphasizes the importance of leadership in resource allocation. Engaging leaders is essential for expanding programs across African countries.
Strategies for Equity and Access
Dr. Sharon Kapambwe from WHO highlighted Africa’s disproportionate burden of cervical cancer and the need for equitable healthcare access. Addressing spatial disparities, especially in urban-rural divides, is vital for broadening access to cervical cancer services.
Pro Tips for Success
Frequently Asked Questions
What are the WHO’s targets for eliminating cervical cancer by 2030?
The WHO’s 90-70-90 targets aim for 90% HPV vaccination coverage by age 15, 70% screening coverage by ages 35 and 45, and 90% treatment coverage for those diagnosed with cervical disease.
Why is the single-dose HPV vaccine strategy important?
The single-dose strategy simplifies distribution and ensures higher coverage, demonstrating that one dose is as effective as two for preventing HPV infections.
How does Africa CDC plan to ensure sustainability?
By establishing a Technical Working Group and Centers of Excellence, Africa CDC plans to promote sustainability through technical guidance and peer learning across the continent.
Future Prospects and Call to Action
As Africa CDC and WHO drive forward their cervical cancer elimination strategies, innovative leadership and community engagement will be crucial. We invite you to explore more articles, comment below with your thoughts, and subscribe to our newsletter for updates on this critical public health initiative.
